Publication | Closed Access

Novel quinoxalinyl chalcone hybrid scaffolds as enoyl ACP reductase inhibitors: Synthesis, molecular docking and biological evaluation

Molecular DockingCombinatorial ChemistryMedicinal ChemistryBioorganic ChemistryBiochemistryNatural SciencesMedicineRational Drug DesignChalcone Hybrid ScaffoldsBiological EvaluationDrug DevelopmentChemical BiologyPharmacologyPharmaceutical ChemistryDrug Discovery